HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

492.301

-8.510-1.70%

Number of Gainers:3

Number of Losers:27

Number of Flat:3

PE:- -

High:501.068

Open:501.068

Low:481.557

Close:500.811

Volume:74.06M

Turnover:1.96B

Market Cap:310.93B

Float Cap:278.82B

Loading ...

Guotai Haitong: AI Drug Discovery Hits Industry Inflection Point as Large Models Reshape Sector Paradigm

Akeso to Raise Approximately HK$1.941 Billion Through Placement of 20 Million Shares

Akeso - to Place 20 Mln New Shares at Hk$97.76 Per Share

THOMSON REUTERS

Ningxiang Life Sciences Cluster Takes Shape After Growing from One Company to Over a Hundred Enterprises

CanSino Biologics Receives Government Income-Related Subsidy; Hong Kong Shares Down 5%

MT Newswires Live

AI Drug Discovery Sector Plunges: GenScript Plummets 18% Intraday, WuXi AppTec Group Falls Across the Board, Hang Seng Stock Connect Healthcare ETF Underlying Index Drops 5.6%

CARsgen Doses First Patient in China Trial of T-Cell Therapy for Multiple Myeloma

MT Newswires Live

SCIENTECH Gains Medical Device Registration Certificate for MemoCarna Patent Foramen Ovale Occluder

Should Phase III Colon Cancer Trial Require Action From Akeso (SEHK:9926) Investors?

Simply Wall St.

Ascletis Pharma-B Repurchases 200,000 Shares for Approximately HK$1.3703 Million on October 12

Shanghai Kehua Bio's Norovirus GI and GII Nucleic Acid Typing Detection Kit (Fluorescence PCR Method) Secures Medical Device Registration Certificate

Edding Genor Gets China Approval for Phase 2 GB268 Trial in Colorectal Cancer

MT Newswires Live

Everbright Securities Keeps "Buy" Rating on KEYMED BIO-B (02162) as Commercialization Ramps Up Rapidly

Everest Medicines Surges Over 12% in Morning Trading as Company Accelerates Global mRNA Strategy

How Can Domestic Innovative Drugs Truly Go Global for the Long Haul?

Hong Kong Stock Concept Tracking: Third-Quarter Earnings Season Begins! AI and Innovative Drugs in Focus, How Should Investors Position for the Q3 Earnings Rally? (With Concept Stocks)

Harbin Pharmaceutical Group President Lu Chuanyou Placed Under Investigation and Detention; Company Says Operations Remain Normal

China Securities Co., Ltd. Third Quarter 2026 Outlook on Pharma, Medical Devices and Services

Harbin Pharmaceutical's 64-Year-Old President Placed Under Detention; Earned Over 2.96 Million Yuan Last Year, Once Served as Chairman of Sanjing Pharmaceutical, Stock Once Rose 200% in 30 Trading Days

Breakeven On The Horizon For CARsgen Therapeutics Holdings Limited (HKG:2171)

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketd.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":492.301,"timestamp":1791878906339,"preClose":500.8114,"halted":0,"volume":74064459,"delay":0,"changeRate":-0.016993,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-8.510406,"latestTime":"10-13 16:00:00","open":501.06766,"high":501.06766,"low":481.5568,"amount":1955398739.5,"amplitude":0.038959,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791855000000,1791864000000],[1791867600000,1791878400000]],"pbRate":3.649269,"peRate":162.110726,"turnoverRate":0.002775,"increases":3,"decrements":26,"flats":3,"marketCap":310934550112,"floatMarketCap":278824693896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":501.06766,"amplitude":0.038959,"preClose":500.8114,"low":481.5568,"pbRate":"3.649269","latestPrice":492.301,"volume":74064459,"delay":0,"open":501.06766,"prevYearClose":556.26263,"prevWeekClose":503.547,"prevMonthClose":532.388,"prevQuarterClose":532.388,"fiveDayClose":534.856,"twentyDayClose":502.512,"sixtyDayClose":494.234,"secType":"PLATE","market":"HK","turnoverRate":0.002775,"peRate":162.110726,"marketCap":310934550112,"floatMarketCap":278824693896,"timestamp":1791878906339,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":3,"down":27,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1109237617","title":"Guotai Haitong: AI Drug Discovery Hits Industry Inflection Point as Large Models Reshape Sector Paradigm","url":"https://stock-news.laohu8.com/highlight/detail?id=1109237617","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109237617?lang=en_us&edition=fundamental","pubTime":"2026-10-14 07:00","pubTimestamp":1791932419,"startTime":"0","endTime":"0","summary":"According to a research report from Guotai Haitong (ASX: 601211), the key difference between this round of AIDD and the previous one lies in AI upgrading from a search efficiency tool to a system...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","BK1191","BK0276","GPTZ","BK0184","BK0183","BK1564","VTHR","LRNZ","BK1574","02611","BK0188","QTOC","01477","BK0028","AIPO","WISE","BK0012","AGIX","601211","CHAT","ARTY","EPAI","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133814227","title":"Akeso to Raise Approximately HK$1.941 Billion Through Placement of 20 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1133814227","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133814227?lang=en_us&edition=fundamental","pubTime":"2026-10-14 06:40","pubTimestamp":1791931219,"startTime":"0","endTime":"0","summary":"Akeso (09926) has announced that on October 14, 2026, before the trading session, the company entered into a placement agreement with placing agents. The company has conditionally agreed to place a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","IE00B543WZ88.USD","LU0417516571.SGD","IE00B5MMRT66.SGD","LU1961090484.USD","LU0348766576.USD","LU0634319403.HKD","LU0348827113.USD","LU2488822045.USD","LU2476274720.SGD","LU2778985437.USD","BK1161","LU0561508036.HKD","LU0348767384.USD","LU0348735423.USD","IE00BPRC5H50.USD","BK1574","LU0348783233.USD","LU0348784397.USD","LU0417516738.SGD","LU0417516902.SGD","LU1720050803.USD","09926","LU2476274308.USD","LU2399975544.HKD","KURE","LU1794554557.SGD","LU0540923850.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675988953","title":"Akeso - to Place 20 Mln New Shares at Hk$97.76 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2675988953","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675988953?lang=en_us&edition=fundamental","pubTime":"2026-10-14 06:07","pubTimestamp":1791929224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nFWN45Z1PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0348766576.USD","LU0348825331.USD","LU0348827113.USD","LU0634319403.HKD","IE00B543WZ88.USD","LU2476274308.USD","LU1794554557.SGD","LU2399975544.HKD","BK1161","IE00BPRC5H50.USD","LU2778985437.USD","LU2476274720.SGD","LU0540923850.HKD","LU0561508036.HKD","IE00B5MMRT66.SGD","09926","LU1720050803.USD","LU0417516738.SGD","LU0348784397.USD","LU0348735423.USD","LU0348783233.USD","LU2488822045.USD","LU0417516902.SGD","LU0348767384.USD","BK1574","LU0417516571.SGD","LU1961090484.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143651372","title":"Ningxiang Life Sciences Cluster Takes Shape After Growing from One Company to Over a Hundred Enterprises","url":"https://stock-news.laohu8.com/highlight/detail?id=1143651372","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143651372?lang=en_us&edition=fundamental","pubTime":"2026-10-14 04:51","pubTimestamp":1791924695,"startTime":"0","endTime":"0","summary":"From October 20 to 22, by the banks of Shanghai's Huangpu River, the 2026 Sustainable Global Leaders Conference returns once again. Nobel laureates and Turing Award winners will take the stage to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGNG","MDEV","LNGR","BK1583","BK1100","BK1574","RSPH","GDOC","09996","HART","IEIH","MEDX","LGHT","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675333086","title":"CanSino Biologics Receives Government Income-Related Subsidy; Hong Kong Shares Down 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675333086","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675333086?lang=en_us&edition=fundamental","pubTime":"2026-10-13 14:17","pubTimestamp":1791872239,"startTime":"0","endTime":"0","summary":"CanSino Biologics  received a government income-related subsidy of 2.9 million yuan, according to a Tuesday filing with the Shanghai bourse.The subsidy amount is equivalent to 10% of the company's audited net profit for its most recent fiscal year, the filing said.The drug company's Hong Kong shares fell 5% while its Shanghai-traded shares slipped 3 on Tuesday afternoon.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","BK1161","BK0239","BK1574","688185","06185","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105388893","title":"AI Drug Discovery Sector Plunges: GenScript Plummets 18% Intraday, WuXi AppTec Group Falls Across the Board, Hang Seng Stock Connect Healthcare ETF Underlying Index Drops 5.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1105388893","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105388893?lang=en_us&edition=fundamental","pubTime":"2026-10-13 11:30","pubTimestamp":1791862233,"startTime":"0","endTime":"0","summary":"On the morning of October 13, the AI drug discovery theme experienced a sudden sharp decline, with the CXO concept taking a heavy hit.Hong Kong-listed GenScript Biotech Corporation (HKEX: 1548)...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","CHAT","BK1574","FLHK","159137","512170","01477","AIPO","QTOC","VTHR","BK1191","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675238484","title":"CARsgen Doses First Patient in China Trial of T-Cell Therapy for Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2675238484","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675238484?lang=en_us&edition=fundamental","pubTime":"2026-10-13 10:15","pubTimestamp":1791857704,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics  dosed the first patient in a registrational Phase 1 trial in China of CT0596, an allogeneic CAR T-cell therapy targeting BCMA for relapsed or refractory multiple myeloma, according to a Tuesday Hong Kong bourse filing.Earlier investigator-initiated trials showed preliminary favorable tolerability and encouraging efficacy signals in patients with relapsed or refractory multiple myeloma and primary plasma cell leukemia, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1587","02171","BK1161","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192006897","title":"SCIENTECH Gains Medical Device Registration Certificate for MemoCarna Patent Foramen Ovale Occluder","url":"https://stock-news.laohu8.com/highlight/detail?id=1192006897","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192006897?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:20","pubTimestamp":1791811219,"startTime":"0","endTime":"0","summary":"SCIENTECH (02291) has announced that its wholly-owned subsidiary, Shanghai Shape Memory Alloy Material Co., Ltd., has obtained a medical device registration certificate (registration certificate...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","PTH","LNGR","LGHT","BK1100","02291","159883","IEIH","AGNG","MDEV","GDOC","RSPH","BK1574","09996","BK1583","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674806848","title":"Should Phase III Colon Cancer Trial Require Action From Akeso (SEHK:9926) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2674806848","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674806848?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:27","pubTimestamp":1791804462,"startTime":"0","endTime":"0","summary":"Akeso reported that the first patient has been dosed in a Phase III trial of cadonilimab as perioperative monotherapy for resectable MSI-H/dMMR colon cancer, expanding the antibody's evaluation beyond gastric, lung, and cervical indications.\nThe move into perioperative colon cancer targets an area where conventional chemotherapy delivers around 7% pathological response rates. If outcomes are positive, this could influence how Akeso allocates R&D and commercial resources around...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/should-phase-iii-colon-cancer-trial-require-action-from-akes","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/should-phase-iii-colon-cancer-trial-require-action-from-akes","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0348784397.USD","BK1161","LU2778985437.USD","BK4211","IE00BPRC5H50.USD","LU0348783233.USD","LU1961090484.USD","LU1794554557.SGD","LU0540923850.HKD","LU0417516738.SGD","LU0348825331.USD","KURE","LU0417516902.SGD","BK1574","LU0561508036.HKD","LU0348767384.USD","LU0634319403.HKD","LU2488822045.USD","LU0348735423.USD","LU2399975544.HKD","LU2476274308.USD","IE00B5MMRT66.SGD","09926","LU0417516571.SGD","LU1720050803.USD","LU2476274720.SGD","LU0348766576.USD","ISBC","LU0348827113.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168718640","title":"Ascletis Pharma-B Repurchases 200,000 Shares for Approximately HK$1.3703 Million on October 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1168718640","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168718640?lang=en_us&edition=fundamental","pubTime":"2026-10-12 18:58","pubTimestamp":1791802700,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) announced that on October 12, 2026, it spent approximately HK$1.3703 million to repurchase 200,000 shares.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","BK1574","BK1191","01477","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126019746","title":"Shanghai Kehua Bio's Norovirus GI and GII Nucleic Acid Typing Detection Kit (Fluorescence PCR Method) Secures Medical Device Registration Certificate","url":"https://stock-news.laohu8.com/highlight/detail?id=1126019746","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126019746?lang=en_us&edition=fundamental","pubTime":"2026-10-12 16:10","pubTimestamp":1791792624,"startTime":"0","endTime":"0","summary":"Shanghai Kehua Bio-Engineering Co.,Ltd. (002022.SZ) has announced that its controlling subsidiary, Suzhou Tianlong Biotechnology Co., Ltd., recently received a medical device registration certificate...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","MEDX","GDOC","IEIH","PTH","PCR","BK0046","BK0188","BK0239","LGHT","BK1100","09996","BK1574","BK1583","MDEV","HART","AGNG","002022","BK0028","LNGR","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674823949","title":"Edding Genor Gets China Approval for Phase 2 GB268 Trial in Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2674823949","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674823949?lang=en_us&edition=fundamental","pubTime":"2026-10-12 11:29","pubTimestamp":1791775788,"startTime":"0","endTime":"0","summary":"Edding Genor Group Holdings  received approval from China's National Medical Products Administration for a Phase 2 clinical trial of its investigational drug GB268 in advanced colorectal cancer, according to a Sunday Hong Kong bourse filing.The trial will evaluate GB268, a PD-1/CTLA-4/VEGF trispecific antibody, in combination with chemotherapy as a first-line treatment for patients with locally advanced or metastatic colorectal cancer that cannot be treated through curative surgery or local therapy.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","06998","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158067159","title":"Everbright Securities Keeps \"Buy\" Rating on KEYMED BIO-B (02162) as Commercialization Ramps Up Rapidly","url":"https://stock-news.laohu8.com/highlight/detail?id=1158067159","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158067159?lang=en_us&edition=fundamental","pubTime":"2026-10-12 11:14","pubTimestamp":1791774857,"startTime":"0","endTime":"0","summary":"According to a research report from Everbright Securities Company Limited (601788), considering the rapid revenue growth of KEYMED BIO-B's (02162) core product Kangyueda in 26H1 and the substantial...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0276","BK1583","601788","BK1574","BK0183","BK0028","BK1161","BK0188","02162","BK1587","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137700782","title":"Everest Medicines Surges Over 12% in Morning Trading as Company Accelerates Global mRNA Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1137700782","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137700782?lang=en_us&edition=fundamental","pubTime":"2026-10-12 09:51","pubTimestamp":1791769874,"startTime":"0","endTime":"0","summary":"Everest Medicines (01952) rose more than 12% in morning trading, with shares up 12.37% as of press time to HK$33.26, on turnover of HK$162 million.U.S. vaccine stocks rallied sharply last Friday,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01952","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165202895","title":"How Can Domestic Innovative Drugs Truly Go Global for the Long Haul?","url":"https://stock-news.laohu8.com/highlight/detail?id=1165202895","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165202895?lang=en_us&edition=fundamental","pubTime":"2026-10-12 07:31","pubTimestamp":1791761477,"startTime":"0","endTime":"0","summary":"Since the start of this year, the globalization of domestically developed innovative drugs has continued to advance, with multiple overseas licensing deals being finalized. Meanwhile, the industry is...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1161","LNGR","MEDX","159992","BK1574","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166516380","title":"Hong Kong Stock Concept Tracking: Third-Quarter Earnings Season Begins! AI and Innovative Drugs in Focus, How Should Investors Position for the Q3 Earnings Rally? (With Concept Stocks)","url":"https://stock-news.laohu8.com/highlight/detail?id=1166516380","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166516380?lang=en_us&edition=fundamental","pubTime":"2026-10-12 07:10","pubTimestamp":1791760243,"startTime":"0","endTime":"0","summary":"The third-quarter earnings disclosure window has officially opened, with listed companies beginning to release their results and many issuing advance earnings forecasts, some reporting net profit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","MEDX","QTOC","ARTY","06978","VTHR","AGIX","BK1574","BK4585","AIPO","LNGR","BK4588","159992","BK1161","VXUS","KCAI","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197088385","title":"Harbin Pharmaceutical Group President Lu Chuanyou Placed Under Investigation and Detention; Company Says Operations Remain Normal","url":"https://stock-news.laohu8.com/highlight/detail?id=1197088385","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197088385?lang=en_us&edition=fundamental","pubTime":"2026-10-11 20:30","pubTimestamp":1791721851,"startTime":"0","endTime":"0","summary":"On October 11, Harbin Pharmaceutical Group Co., Ltd. issued an announcement disclosing that the company had recently received a \"Notice of Case Filing\" and a \"Notice of Detention\" from a supervisory...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181917803","title":"China Securities Co., Ltd. Third Quarter 2026 Outlook on Pharma, Medical Devices and Services","url":"https://stock-news.laohu8.com/highlight/detail?id=1181917803","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181917803?lang=en_us&edition=fundamental","pubTime":"2026-10-11 19:50","pubTimestamp":1791719441,"startTime":"0","endTime":"0","summary":"Pharma industry chain: 1) Prescription drugs: innovative access drives performance growth, while internationalization moves from business development to organizational overseas expansion and...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDEV","01477","BK1100","159883","BK1191","LNGR","BK1574","GDOC","IEIH","RSPH","601066","BK1583","MEDX","09996","HART","BK0276","AGNG","PTH","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119173430","title":"Harbin Pharmaceutical's 64-Year-Old President Placed Under Detention; Earned Over 2.96 Million Yuan Last Year, Once Served as Chairman of Sanjing Pharmaceutical, Stock Once Rose 200% in 30 Trading Days","url":"https://stock-news.laohu8.com/highlight/detail?id=1119173430","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119173430?lang=en_us&edition=fundamental","pubTime":"2026-10-11 19:40","pubTimestamp":1791718830,"startTime":"0","endTime":"0","summary":"For stock trading, rely on Jinlin Analyst Research Reports — authoritative, professional, timely, and comprehensive, helping you uncover potential thematic opportunities! The 64-year-old president of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0239","BK1191","BK1574","600664","BK0012","01477","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674450816","title":"Breakeven On The Horizon For CARsgen Therapeutics Holdings Limited (HKG:2171)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674450816","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674450816?lang=en_us&edition=fundamental","pubTime":"2026-10-11 10:05","pubTimestamp":1791684354,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited ( HKG:2171 ) is possibly approaching a major achievement in its business, so we...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/breakeven-on-the-horizon-for-carsgen-therapeutics-holdings-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/breakeven-on-the-horizon-for-carsgen-therapeutics-holdings-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","BK1161","BK4139","BK4007","BK1574","BK4539","BK1587","02171","BK1585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":146,"code":"91000000","status":"200"}]}}